Organised by the Clinical Investigation Center
Nancy Inserm 1433 Clinical Plurithematic Investigation Centre (CIC-P), headed by Pr Faiez Zannad, is supported by the National Institution for Health Care and Medical Research (Inserm), Nancy University Hospital, and the Université de Lorraine.
Endorsed in 2017 by
The Heart Rhythm Society aims to improve the care of patients by advancing research, education and optimal health care policies and standards. The Heart Rhythm Society is a leading resource on cardiac pacing and electrophysiology. This specialty organization represents medical, allied health, and science professionals from more than 70 countries who specialize in cardiac rhythm disorders.
Visit the Website
The Heart Failure Society of America provides a forum for all those interested in heart function, heart failure, and congestive heart failure (CHF) research and patient care. Membership is open to all health care professionals with an interest in cardiovascular medicine, including cardiologists, cardiac surgeons, internists, geriatricians, general and family practitioners, scientists, cardiac rehabilitation specialists, nurses, industry or allied personnel.
Visit the Website
The Kidney Health Initiative (KHI), established in September 2012, is a public private partnership founded by the American Society of Nephrology and the U.S. Food and Drug Administration (FDA). With over 80 member organizations, KHI administers multi-disciplinary projects in order to improve patient safety and foster the development of novel therapies for patients with kidney diseases. Through the leadership and support of the KHI Patient and Family Partnership Council (PFPC), the patient voice
is considered an integral part of all KHI activities.
With the participation of
The Food and Drug Administration (FDA or USFDA) is a federal agency of the United States Department of Health and Human Services, one of the United States federal executive departments. The FDA is responsible for protecting and promoting public health through the regulation and supervision of food safety, tobacco products, dietary supplements, prescription and over-the-counter pharmaceutical drugs (medications), vaccines, biopharmaceuticals, blood transfusions, medical devices, electromagnetic radiation emitting devices, cosmetics, animal foods & feed and veterinary products.
The National Heart, Lung, and Blood Institute (NHLBI) provides global leadership for a research, training, and education program to promote the prevention and treatment of heart, lung, and blood diseases and enhance the health of all individuals so that they can live longer and more fulfilling lives.
Visit the Website
The European Medicines Agency is a decentralised agency of the European Union, located in London. The Agency is responsible for the scientific evaluation of medicines developed by pharmaceutical companies for use in the European Union. It began operating in 1995.
Visit the Website
The mission of the International Society of Cardiovascular Pharmacotherapy (ISCP) is to promote and facilitate strategies to improve cardiovascular health through cooperation among cardiac physicians and surgeons, pharmacologists, pharmacists, scientists, and medical practitioners worldwide.
The European Association for Clinical Pharmacology and Therapeutics (EACPT) is a learned society in the field of clinical pharmacology. It is the leading society in Europe serving the European and global clinical pharmacology and therapeutics community. The EACPT includes all national organisations for clinical pharmacology in Europe and provides educational and scientific support for the more than 4000 individual professionals interested in clinical pharmacology and therapeutics throughout the European region, with its congresses - the next in Madrid in 2015 - attended by a global audience. The EACPT also holds summer schools and organises other scientific and professional activities.
The French Clinical Research Infrastructure Network (F-CRIN), hosted by INSERM, is an operational excellence network encompassing the major French academic actors in clinical research. FCRIN aims to support and promote ambitious and competitive multinational academic investigator-driven trials proposed in France and early development proof of concept with industry sponsored trials. FCRIN acts as a multifunctional platform able to provide all necessary services to the duo Investigator/Sponsor and works in tight connection with ECRIN, ERIC of which France is one of the founding member.
INI (Investigation Network Initiative)-CRCT (Cardiovascular and Renal Clinical Trialists), coordinated by Pr Patrick Rossignol (Nancy, France) has been approved by the “F-CRIN” (French Clinical Research Infrastructure Network). It has established a national multidisciplinary network of research excellence comprised of the French leaders in the cardiorenal field (nephrology, cardiology, intensivists, internists trialists, epidemiologists, methodologists, basic researchers), an Academic Research Organisation, disease management programs in Chronic Kidney disease (CKD) and heart failure, the French Biomedecine agency, and University of Lorraine Foundation. It aims at designing and realizing research programs both nationally and internationally, to improve cardiovascular and renal outcomes in CKD patients. email@example.com